1. P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3-21R110. (23rd June 2022) Authors: Hengeveld, P.; Ertem, Y. E.; Dubois, J.; Mellink, C.; van der Kevie-Kersemaekers, A.-M.; Evers, L.; Heezen, K.; Kolijn, P. M.; Mook, O.; Motazacker, M. M.; Nasserinejad, K.; Kersting, S.; Westerweel, P.; Niemann, C.; Kater, A.; Langerak, A.; Levin, M.-D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P652: MEASURING MINIMAL RESIDUAL DISEASE BEYOND 10-4 THROUGH IGHV LEADER-BASED NEXT GENERATION SEQUENCING IMPROVES PROGNOSTIC STRATIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA. (23rd June 2022) Authors: Hengeveld, P.; van der Klift, M.; Kolijn, P. M.; Davi, F.; Kavelaars, F.; de Jonge, E.; Robrecht, S.; Assmann, J.; van der Straten, L.; Ritgen, M.; Westerweel, P.; Fischer, K.; Goede, V.; Hallek, M.; Levin, M.-D.; Langerak, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗